https://patentbrief.org/company/university-of-pennsylvania-penn Plain-English explanations of patents assigned to University of Pennsylvania Penn, newest first. en-us Sun, 12 Jul 2026 13:24:29 GMT https://patentbrief.org/patent/us/12085565/sntf-is-a-blood-biomarker-for-the-diagnosis-and-prognosis-of-sports-related-conc This patent describes a method to diagnose and predict long-term issues from mild traumatic brain injury, like concussions, by measuring a specific protein fragment called SNTF in a blood sample. Tue, 10 Sep 2024 00:00:00 GMT https://patentbrief.org/patent/us/12085565/sntf-is-a-blood-biomarker-for-the-diagnosis-and-prognosis-of-sports-related-conc https://patentbrief.org/patent/us/9481728/compositions-and-methods-for-treatment-of-cancer This patent describes how to create and use genetically modified human T cells that target and kill cancer cells expressing the CD19 protein, offering a new way to treat blood cancers. Tue, 01 Nov 2016 00:00:00 GMT https://patentbrief.org/patent/us/9481728/compositions-and-methods-for-treatment-of-cancer https://patentbrief.org/patent/us/9328156/use-of-chimeric-antigen-receptor-modified-t-cells-to-treat-cancer This patent describes how human T cells are genetically engineered to express a special receptor (CAR) that specifically targets and kills cancer cells, particularly those with the CD19 marker, offering a new way to treat cancer. Tue, 03 May 2016 00:00:00 GMT https://patentbrief.org/patent/us/9328156/use-of-chimeric-antigen-receptor-modified-t-cells-to-treat-cancer https://patentbrief.org/patent/us/8278036/rna-containing-modified-nucleosides-and-methods-of-use-thereof A breakthrough method for using modified RNA to deliver instructions to cells without causing the body to reject the treatment as a foreign invader. Tue, 02 Oct 2012 00:00:00 GMT https://patentbrief.org/patent/us/8278036/rna-containing-modified-nucleosides-and-methods-of-use-thereof